The Effect of Carbamazepine and Lithium on Remission from Affective Illness
- 1 February 1987
- journal article
- clinical trial
- Published by Royal College of Psychiatrists in The British Journal of Psychiatry
- Vol. 150 (2), 180-182
- https://doi.org/10.1192/bjp.150.2.180
Abstract
Times in remission from affective illness were prolonged during treatment with lithium carbonate and carbamazepine, but lithium was the more effective. Similar global scores for the two drugs suggested that other factors may determine their acceptability.Keywords
This publication has 9 references indexed in Scilit:
- Long-Term Prophylactic Effects of Carbamazepine in Affective DisorderThe British Journal of Psychiatry, 1983
- Carbamazepine, a possible adjunct or alternative to lithium in bipolar disorderActa Psychiatrica Scandinavica, 1983
- A preliminary double-blind study on the efficacy of carbamazepine in prophylaxis of manic-depressive illnessPsychopharmacology, 1981
- Carbamazepine in manic-depressive illness: a new treatmentAmerican Journal of Psychiatry, 1980
- A New Depression Scale Designed to be Sensitive to ChangeThe British Journal of Psychiatry, 1979
- A new scale for measuring maniaPsychological Medicine, 1977
- Methodological Problems of Prophylactic Trials in Recurrent Affective DisordersThe British Journal of Psychiatry, 1970
- Course of Endogenous Affective Psychoses and its Modification by Prophylactic Administration of Imipramine and LithiumInternational Pharmacopsychiatry, 1969
- Development of a Rating Scale for Primary Depressive IllnessBritish Journal of Social and Clinical Psychology, 1967